Market Access Today and Tomorrow

Understand the frameworks that market access operates in and learn how you stay at the forefront of the ongoing development

1. Dec 2021
28. Sep 2022

2 days course

English

12,300 DKK ex VAT
(app. 1,654 EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

SUMMARY

Departing from the current field of market access, this course you will introduce you to key developments within a European, Nordic, and local context that will determine what market access will look like in the future – and what your role will be within market access

Participants will need prior knowledge of market access as well as a willingness to engage with the lectures and course participants. Workshops and group exercises are included in the course so that you may translate key insights from the lectures into a new understanding of the commercial, professional, and organizational challenges that you face now – and will face in the future. 

   

KEYWORDS

  • The future of market access in a European, Nordic, and local context
  • Developments determing the role of the market access expert in the future
  • Framework for future market access strategy

Hi! Do you need help choosing the right course?

We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com

Read more

IS THIS COURSE FOR YOU?

Are you involved in local market access strategy, e.g. as a health economist, tender or reimbursement specialist? Or in other market access or regulatory areas focused on the current and upcoming market situation in Denmark? In that case, join this course. Experienced market access professionals will gain updated knowledge on a dynamic market. If you're new to market access or pharma consultancy, the course provides a quick and broad introduction to the area.

WHAT YOU WILL LEARN 

  1. How political and socio-economic developments impact national healthcare
  2. How public health organizations, regulatory actors, healthcare bodies, priority bodies, and patient organizations work, think, and collaborate
  3. How future medicines, growing patient populations and disease areas will impact the market access arena
  4. How Real World Data/Evidence will be part of authorities’ tool box for evaluating medicines
  5. How stakeholder management and lobby-work will support Market Access now, and in the future
  6. Why Big Data, Machine Learning, and Artificial Intelligence will be an integral part of healthcare and the services that Market Access will deliver in the future
  7. How Health economic studies may come to include new dimensions of “value” to demonstrate the worth of medical treatments in the future
  8. Market Access’ role the future pharma organization

WHAT YOUR COMPANY WILL GET 

  1. An employee who can strategically utilize how political tends frame national healthcare
  2. An employee who can use stakeholder management and lobbyism as an effective tool
  3. An employee who understands how future developments within innovative medicines, patient populations, Real World Evidence, Health economics, and digitalized medicine treatment will set the demands on Market Access professionals’ and organizations’ capabilities

Course calendar

Choose your starting date
Starting 1. Dec 2021
Starting 28. Sep 2022
1. Dec 2021 9:00-16:00

DAY 1

  • Introduction to the course
  • Political, economic, and sociodemographic developments
  • Stakeholder, authorities, and Priority/ HTA bodies
  • Future medicines and disease areas
  • Real World Data/Evidence – toward utilization big data in safety and development
2. Dec 2021 9:00-16:00

DAY 2

  • Lobbyism – managing interests and informing stakeholder
  • Digitalization – from drug to digitized medical treatment
  • Health Economics – values and worth
  • Market Access in pharma organizations – Collaborations and organization
  • Rap-up and evaluation
Practical information

Registration

Registration deadline
24. Nov 2021
Atrium
Lersø Parkallé 101
2100 København Ø
28. Sep 2022 9:00-16:00

DAY 1

  • Introduction to the course
  • Political, economic, and sociodemographic developments
  • Stakeholder, authorities, and Priority/ HTA bodies
  • Future medicines and disease areas
  • Real World Data/Evidence – toward utilization big data in safety and development
29. Sep 2022 9:00-16:00

DAY 2

  • Lobbyism – managing interests and informing stakeholder
  • Digitalization – from drug to digitized medical treatment
  • Health Economics – values and worth
  • Market Access in pharma organizations – Collaborations and organization
  • Rap-up and evaluation
Practical information

Registration

Registration deadline
27. Sep 2022
Atrium
Lersø Parkallé 101
2100 København Ø
Sometimes things change. This is the expected programme.

Course information

Literature

Prior to the course you will get access to mandatory and optional readings via your personal Atrium log-in.

Please familiarize yourself with the mandatory readings before starting the course.

The mandatory readings are also part of the examination syllabus. 

Examination

There is no exam for this course.

This course is a part of this programme

Market Access Programme

Our Market Access Programme provides you with in-depth knowledge of the Danish healthcare system and its funding models and stakeholders. Raise your skill level in areas such as public affairs, stakeholder management and health economics by attending the four courses

Read more
Pharma Business Programme

Understand the pharmaceutical market and learn how to work with USPs and manage brands and products. This Pharma Business Programme gives you a solid introduction to the cornerstones of the pharma industry’s commercial activities in a digital and global age

Read more
Pharma Consultant Programme

Design a medical training programme that fits your professional interests. Relevant if you work with or advice on drugs, maybe as a professional in sales and marketing, market access or public affairs in the pharma industry

Read more

You may also be interested in these courses

WANT TO KNOW MORE or need help?

Contact Client Manager Birger Flinthagen at +45 39 15 09 06

Send me a message